{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:32:57Z","timestamp":1790937177018,"version":"4.1.0"},"reference-count":43,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2011,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Six poliovirus-neutralizing Fabs were recovered from a combinatorial Fab phage display library constructed from bone marrow-derived lymphocytes of immunized chimpanzees. The chimeric chimpanzee-human full-length IgGs (hereinafter called monoclonal antibodies [MAbs]) were generated by combining a chimpanzee IgG light chain and a variable domain of heavy chain with a human constant Fc region. The six MAbs neutralized vaccine strains and virulent strains of poliovirus. Five MAbs were serotype specific, while one MAb cross-neutralized serotypes 1 and 2. Epitope mapping performed by selecting and sequencing antibody-resistant viral variants indicated that the cross-neutralizing MAb bound between antigenic sites 1 and 2, thereby covering the canyon region containing the receptor-binding site. Another serotype 1-specific MAb recognized a region located between antigenic sites 2 and 3 that included parts of capsid proteins VP1 and VP3. Both serotype 2-specific antibodies recognized antigenic site 1. No escape mutants to serotype 3-specific MAbs could be generated. The administration of a serotype 1-specific MAb to transgenic mice susceptible to poliovirus at a dose of 5 \u03bcg\/mouse completely protected them from paralysis after challenge with a lethal dose of wild-type poliovirus. Moreover, MAb injection 6 or 12 h after virus infection provided significant protection. The MAbs described here could be tested in clinical trials to determine whether they might be useful for treatment of immunocompromised chronic virus excretors and for emergency protection of contacts of a paralytic poliomyelitis case.<\/jats:p>","DOI":"10.1128\/jvi.02553-10","type":"journal-article","created":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T04:23:04Z","timestamp":1298521384000},"page":"4354-4362","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":42,"title":["Chimpanzee-Human Monoclonal Antibodies for Treatment of Chronic Poliovirus Excretors and Emergency Postexposure Prophylaxis"],"prefix":"10.1128","volume":"85","author":[{"given":"Zhaochun","family":"Chen","sequence":"first","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Chumakov","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Rockville, Maryland 20852"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Dragunsky","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Rockville, Maryland 20852"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Kouiavskaia","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Rockville, Maryland 20852"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Makiya","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Neverov","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Rockville, Maryland 20852"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennady","family":"Rezapkin","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Rockville, Maryland 20852"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Sebrell","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Purcell","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.14.1696"},{"key":"e_1_3_2_3_2","first-page":"497","article-title":"Maintenance and distribution of transgenic mice susceptible to human viruses: memorandum from a WHO meeting","volume":"71","author":"Anonymous","year":"1993","unstructured":"Anonymous. 1993. Maintenance and distribution of transgenic mice susceptible to human viruses: memorandum from a WHO meeting. Bull. World Health Organ. 71:497\u2013502.","journal-title":"Bull. World Health Organ."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.1.73"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00906-07"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0510598103"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0906581106"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/500148"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1086\/593310"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1994.tb06930.x"},{"key":"e_1_3_2_11_2","unstructured":"Committee on Development of a Polio Antiviral and Its Potential Role in Global Poliomyelitis Eradication National Research Council. 2006. Exploring the role of antiviral drugs in the eradication of polio. National Academies Press Washington DC."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2004.05.005"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.401"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60597-8"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1586\/erv.09.49"},{"key":"e_1_3_2_16_2","unstructured":"FoxJ. P.\nHallC. E.. 1980. Viruses in families: surveillance of families as a key to epidemiology of virus infections p. 131-135. PSG Publishing Company Inc. Littleton MA."},{"key":"e_1_3_2_17_2","first-page":"357","article-title":"Passive immunization against poliomyelitis","volume":"26","author":"Hammon W. M.","year":"1955","unstructured":"HammonW. M.. 1955. Passive immunization against poliomyelitis. Monogr. Ser. World Health Organ. 26:357\u2013370.","journal-title":"Monogr. Ser. World Health Organ."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/434699a"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.36.2.841-843.1982"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.4.2.167"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.10.2893-2899.1998"},{"key":"e_1_3_2_22_2","first-page":"16","article-title":"Circulating vaccine-derived polioviruses: current state of knowledge","volume":"82","author":"Kew O. M.","year":"2004","unstructured":"KewO. M. . 2004. Circulating vaccine-derived polioviruses: current state of knowledge. Bull. World Health Organ. 82:16\u201323.","journal-title":"Bull. World Health Organ."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16150-3"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-89-21736"},{"key":"e_1_3_2_25_2","first-page":"75","article-title":"Characteristics of poliovirus strains from long-term excretors with primary immunodeficiencies","volume":"105","author":"Minor P.","year":"2001","unstructured":"MinorP.. 2001. Characteristics of poliovirus strains from long-term excretors with primary immunodeficiencies. Dev. Biol. (Basel) 105:75\u201380.","journal-title":"Dev. Biol. (Basel)"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.02.071"},{"key":"e_1_3_2_27_2","first-page":"141","article-title":"Antigenic structure of poliovirus","volume":"3","author":"Minor P. D.","year":"1986","unstructured":"MinorP. D.. 1986. Antigenic structure of poliovirus. Microbiol. Sci. 3:141\u2013144.","journal-title":"Microbiol. Sci."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909383"},{"key":"e_1_3_2_29_2","unstructured":"National Institutes of Health. 1985. Guide for the care and use of laboratory animals. NIH publication no. 85-23. U.S. Department of Health and Human Services Washington DC."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00671-09"},{"key":"e_1_3_2_31_2","first-page":"723","volume-title":"Fields virology","author":"Pallansch M. A.","year":"2001","unstructured":"PallanschM. A. RoosR. P.. 2001. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses, p. 723\u2013775. In KnipeD. M. HowleyP. M. GriffinD. E. LambR. A. MartinM. A. RoizmanB. StrausS. E. (ed.), Fields virology, 4th ed. Lippincott Williams and Wilkins, Philadelphia, PA.","edition":"4"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1086\/651611"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2004.11.003"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2010.07.037"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2004.040790"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1957.62980110008008"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.44.5.563"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/269420a0"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1080"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(88)90251-6"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-64-12-2809"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(90)90363-V"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsb0897-666"},{"key":"e_1_3_2_44_2","unstructured":"World Health Organization. 1997. Manual for the virological investigation of polio. World Health Organization Geneva Switzerland."}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.02553-10","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.02553-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T16:29:47Z","timestamp":1646497787000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.02553-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["10.1128\/JVI.02553-10"],"URL":"https:\/\/doi.org\/10.1128\/jvi.02553-10","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"2010-12-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-02-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-04-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}